152 related articles for article (PubMed ID: 7477048)
1. Do persons living near a uranium processing site have evidence of increased somatic cell gene mutations? A first study.
Wones R; Radack K; Martin V; Mandell K; Pinney S; Buncher R
Mutat Res; 1995 Oct; 335(2):171-84. PubMed ID: 7477048
[TBL] [Abstract][Full Text] [Related]
2. Intercorrelations and sources of variability in three mutagenicity assays: a population-based study.
Radack K; Martin V; Wones R; Buncher R; Pinney S; Mandell K
Mutat Res; 1996 Mar; 350(2):295-306. PubMed ID: 8600359
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
4. Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age.
Finette BA; Sullivan LM; O'Neill JP; Nicklas JA; Vacek PM; Albertini RJ
Mutat Res; 1994 Jul; 308(2):223-31. PubMed ID: 7518049
[TBL] [Abstract][Full Text] [Related]
5. Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies.
Bigbee WL; Fuscoe JC; Grant SG; Jones IM; Gorvad AE; Harrington-Brock K; Strout CL; Thomas CB; Moore MM
Mutat Res; 1998 Feb; 397(2):119-36. PubMed ID: 9541637
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity monitoring following battlefield exposures: Longitudinal study of HPRT mutations in Gulf War I veterans exposed to depleted uranium.
Albertini RJ; Vacek PM; Carter EW; Nicklas JA; Squibb KS; Gucer PW; Engelhardt SM; McDiarmid MA
Environ Mol Mutagen; 2015 Aug; 56(7):581-93. PubMed ID: 25914368
[TBL] [Abstract][Full Text] [Related]
7. HPRT and glycophorin A mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts.
Perera FP; Tang DL; O'Neill JP; Bigbee WL; Albertini RJ; Santella R; Ottman R; Tsai WY; Dickey C; Mooney LA
Carcinogenesis; 1993 May; 14(5):969-73. PubMed ID: 8504491
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of somatic mutations in human umbilical cord blood to maternal environments.
Manchester DK; Nicklas JA; O'Neill JP; Lippert MJ; Grant SG; Langlois RG; Moore DH; Jensen RH; Albertini RJ; Bigbee WL
Environ Mol Mutagen; 1995; 26(3):203-12. PubMed ID: 7588645
[TBL] [Abstract][Full Text] [Related]
9. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
10. Frequencies of hprt mutant lymphocytes in smokers, non-smokers, and former smokers.
Ammenheuser MM; Hastings DA; Whorton EB; Ward JB
Environ Mol Mutagen; 1997; 30(2):131-8. PubMed ID: 9329637
[TBL] [Abstract][Full Text] [Related]
11. Hprt mutant frequency and GSTM1 genotype in non-smoking healthy individuals.
Hou SM; Fält S; Steen AM
Environ Mol Mutagen; 1995; 25(2):97-105. PubMed ID: 7698112
[TBL] [Abstract][Full Text] [Related]
12. Influence of smoking and donor age on the spectrum of in vivo mutation at the HPRT-locus in T lymphocytes of healthy adults.
Podlutsky A; Hou SM; Nyberg F; Pershagen G; Lambert B
Mutat Res; 1999 Dec; 431(2):325-39. PubMed ID: 10635998
[TBL] [Abstract][Full Text] [Related]
13. Mutation rates at the glycophorin A and HPRT loci in uranium miners exposed to radon progeny.
Shanahan EM; Peterson D; Roxby D; Quintana J; Morely AA; Woodward A
Occup Environ Med; 1996 Jul; 53(7):439-44. PubMed ID: 8704866
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of styrene exposure in lamination workers: levels of O6-guanine DNA adducts, DNA strand breaks and mutant frequencies in the hypoxanthine guanine phosphoribosyltransferase gene in T-lymphocytes.
Vodicka P; Bastlová T; Vodicková L; Peterková K; Lambert B; Hemminki K
Carcinogenesis; 1995 Jul; 16(7):1473-81. PubMed ID: 7614680
[TBL] [Abstract][Full Text] [Related]
15. In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients.
Albertini MR; King DM; Newton MA; Vacek PM
Mutat Res; 2001 May; 476(1-2):83-97. PubMed ID: 11336986
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
Meng Q; Henderson RF; Chen T; Heflich RH; Walker DM; Bauer MJ; Reilly AA; Walker VE
Mutat Res; 1999 Aug; 429(1):107-25. PubMed ID: 10434027
[TBL] [Abstract][Full Text] [Related]
17. Mutational spectra at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus in T-lymphocytes of nonsmoking and smoking lung cancer patients.
Hackman P; Hou SM; Nyberg F; Pershagen G; Lambert B
Mutat Res; 2000 Jun; 468(1):45-61. PubMed ID: 10863157
[TBL] [Abstract][Full Text] [Related]
18. Frequencies of HPRT- lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors.
Sala-Trepat M; Boyse J; Richard P; Papadopoulo D; Moustacchi E
Mutat Res; 1993 Sep; 289(1):115-26. PubMed ID: 7689157
[TBL] [Abstract][Full Text] [Related]
19. An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets.
Robinson DR; Goodall K; Albertini RJ; O'Neill JP; Finette B; Sala-Trepat M; Moustacchi E; Tates AD; Beare DM; Green MH
Mutat Res; 1994; 313(2-3):227-47. PubMed ID: 7523908
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting HPRT mutant frequency in T-lymphocytes of smokers and nonsmokers.
Jones IM; Moore DH; Thomas CB; Thompson CL; Strout CL; Burkhart-Schultz K
Cancer Epidemiol Biomarkers Prev; 1993; 2(3):249-60. PubMed ID: 8318878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
